FDA MedWatch

FDA MedWatch

MedWatch Safety Alerts from the Food and Drug Administration (FDA)

FDA MedWatch
Updated : Thu, 04 Sep 2008 16:37:00 EDT

Tumor necrosis factor-α blockers (TNF blockers), Cimzia (certolizumab pegol), Enbrel (etanercept), Humira (adalimumab), and Remicade (infliximab)
Opportunistic infections are not consistently recognized in patients taking tumor necrosis factor-α blockers.
Publ.Date : Thu, 04 Sep 2008 16:37:00 EDT

September 2008 Patient Safety News
Video news show for healthcare professionals, covering safety alerts, recalls, product approvals, and important tips on protecting patients.
Publ.Date : Sat, 30 Aug 2008 11:45:00 EDT

Pacific Consolidated brand Mobile Oxygen Storage Tank
Class I Recall because the device's pressure gauge may rupture and may catch fire as a result of hydraulic fluid present in the pressure gauge tubing.
Publ.Date : Mon, 28 Aug 2008 14:40:00 EDT

Tysabri (natalizumab)
Two new cases of progressive multifocal leukoencephalopathy in European patients receiving Tysabri as monotherapy for multiple sclerosis for more than one year.
Publ.Date : Mon, 25 Aug 2008 15:22:00 EDT

Ezetimibe/Simvastatin (Vytorin); Simvastatin (Zocor); and Ezetimibe (Zetia)
Report of SEAS trial of a possible association between the use of Vytorin and a potential increased incidence of cancer.
Publ.Date : Thu, 21 Aug 2008 19:55:00 EDT